| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |